B
Beijing Errui Xinyue Technology
Biotech firm focused on developing early diagnostic tech and products for neurodegenerative diseases
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- China
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Neurology, Degenerative Diseases, Health Diagnostics, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Beijing Errui Xinyue Technology.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2026 | $4.1M | $69M | Sunz Fund · Venture Valley Capital | ↗ |
| SERIES A✓Equity / VC | Dec 2025 | $14M | $55M | Shenzhen Guozhong Venture Capital Management · SBI Group | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- SFSunz Fund
Series A3 investors entered at this stage
Shenzhen Guozhong Venture Capital Management
SBI Group- VCVenture Valley Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beijing Errui Xinyue Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beijing Errui Xinyue Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.